Stockreport

FDA on board with endpoint change in study of BeyondSpring's Plinabulin [Seeking Alpha]

BeyondSpring, Inc. - Ordinary Shares  (BYSI) 
Last beyondspring, inc. - ordinary shares earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.beyondspringpharma.com
PDF BeyondSpring (BYSI+4.5%announcesStudy 106The new primary endpoint is the rate of prevention of Grade 4 (life-threatening) neutropenia rather than the duration, the forme [Read more]